Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Abbott Laboratories company logo
Abbott Laboratories logo

Abbott Laboratories (ABT) CFF

Annual CFF

-$6.31B$905.00M-16.75%

Summary

As of today, ABT annual cash from financing is -$6.31B, down -16.75% on
ABT annual cash from financing is up +17.38% over the past 3 years, down -127.02% over the past 5 years
ABT annual cash from financing is currently -156.60% below its historical high of $11.15B set on
ABT annual cash from financing is +17.38% above its 3-year low of -$7.64B reached on an earlier date
ABT annual cash from financing is higher than 1.06% of companies in Healthcare sector

Cash From Financing Chart

SUGGESTED SERIES

Performance

ABT Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing-$6.31B-16.8%+17.4%-127.0%-480.0%
Quarterly Cash From Financing-$3.52B-220.7%-172.9%-178.3%-153.8%
TTM Cash From Financing$10.64B+261.4%+286.7%+315.6%+473.1%
Price$110.91-15.3%+5.3%-9.7%+365.8%
Annual Cash From Operations$9.57B+11.8%-0.2%+21.1%+9.5%
Annual Cash From Investing-$2.42B-3.6%-39.2%-9.3%+80.1%
Annual Dividends Paid$4.12B+7.3%+24.4%+60.8%+54.1%
Annual Total Debt$14.14B-7.5%-21.2%-28.9%-25.3%
Shares Outstanding1.73B-0.6%-0.3%-2.4%–

Cash From Financing Highs

ABT Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y-$5.40B-16.8%
5Y-$2.78BN/A-127.0%
All$11.15B-156.6%

Cash From Financing Lows

ABT Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y-$7.64BN/A+17.4%
5Y-$7.64B+17.4%
All-$10.39B+39.3%

Cash From Financing History

YearValueChange
-$6.31B-16.7%
-$5.40B+23.8%
-$7.09B+7.1%
-$7.64B-39.0%
-$5.49B-97.7%
-$2.78B+35.2%
-$4.29B+58.7%
-$10.39B-96.8%
-$5.28B-147.4%
$11.15B+598.5%
-$2.24B+18.5%
-$2.74B+59.1%
-$6.70B-3,533.8%
$195.00M+103.2%
-$6.02B-453.8%
-$1.09B-208.6%
$1.00B+128.7%
-$3.49B-50.7%
-$2.31B-163.9%
$3.62B+239.7%
-$2.59B-127.7%
-$1.14B+43.3%
-$2.01B+13.2%
YearValueChange
-$2.31B-150.0%
$4.62B+315.3%
-$2.15B-50.5%
-$1.43B-15.7%
-$1.23B+5.7%
-$1.31B-120.9%
-$592.29M+36.6%
-$933.87M+27.0%
-$1.28B-48.2%
-$863.87M-31.4%
-$657.48M+15.7%
-$779.82M-39.7%
-$558.21M+40.4%
-$935.92M-138.4%
-$392.57M+0.7%
-$395.18M-16.7%
-$338.77M+15.9%
-$402.60M-401.1%
-$80.35M+15.6%
-$95.24M+42.8%
-$166.39M-224.5%
-$51.28M+55.0%
-$113.95M-

FAQ

What is the current annual cash from financing of ABT?
As of today, ABT annual cash from financing is -$6.31B
What is 1-year change in ABT annual cash from financing?
ABT annual cash from financing is down -16.75% year-over-year
What is 3-year change in ABT annual cash from financing?
ABT annual cash from financing is up +17.38% over the past 3 years
How far is ABT annual cash from financing from its all-time high?
ABT annual cash from financing is currently -156.60% below its historical high of $11.15B set on December 31, 2016
How does ABT annual cash from financing rank versus sector peers?
ABT annual cash from financing is higher than 1.06% of companies in Healthcare sector
When is ABT next annual earnings release?
As of today, the next annual earnings release for ABT has not been scheduled

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. ABT Official Website www.abbott.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm
  3. ABT Profile on Yahoo Finance finance.yahoo.com/quote/ABT
  4. ABT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abt